On December 10, 2020 Excyte Biopharma reported the company has completed a round A financing of tens of millions of yuan, which was jointly led by Detong Capital and Qianhai Master Fund (Press release, Excyte Biopharma, DEC 10, 2020, View Source;lang=en [SID1234646272]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!